ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 36373 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 36373; 2) Community: the network communities that were significantly associated with the response to NSC 36373; 3) Molecule: the relationships between components within communities and NSC 36373; 4) MDR: the compounds that were significantly associated with the NSC 36373.

NSC Compound Enrichment Correlation
NSC 744693 Null 0.0422011701988039 0.46458201
NSC 748148 5-iodo-2-{[(2)-3-(2-chlorophenyl)prop-2-enoyl]amino}benzamide 0.0422011701988039 0.57882842
NSC 748541 1-Methylene-2-(4-methoxybenzyl)-3-(3-chlorophenyl)-1,2-dihydropyrazino[1,2-a]-benzimidazole 0.0422011701988039 0.31036655
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.0422011701988039 0.25410608
NSC 753734 7alpha-acetoxyroylenane 0.0422011701988039 -0.12835172
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.0422011701988039 0.43891193
NSC 758845 Null 0.0422011701988039 0.25434308
NSC 763232 Null 0.0422011701988039 0.10366236
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0422011701988039 0.10334352
NSC 87500 Solacongestidine 0.0422011701988039 0.22420473
Total:129  Current:104    [First] [Prev] [Next] [Last]